当前位置:首页 - 行情中心 - 永顺生物(920729) - 财务分析 - 现金流量表

永顺生物

(920729)

  

流通市值:5.43亿  总市值:19.16亿
流通股本:7750.70万   总股本:2.73亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金92,045,821.0346,525,651.28273,203,456.01199,825,102.97
  收到其他与经营活动有关的现金6,527,042.054,201,816.484,013,556.013,579,364.95
  经营活动现金流入小计98,572,863.0850,727,467.76277,217,012.02203,404,467.92
  购买商品、接受劳务支付的现金32,640,247.6118,481,732.0362,754,107.7341,205,947.01
  支付给职工以及为职工支付的现金29,389,952.4917,108,843.7255,144,709.9542,751,436.77
  支付的各项税费9,152,2303,984,887.611,499,951.038,651,592.28
  支付其他与经营活动有关的现金24,482,566.7710,862,413.8347,785,547.936,133,852.88
  经营活动现金流出小计95,664,996.8750,437,877.18177,184,316.61128,742,828.94
  经营活动产生的现金流量净额2,907,866.21289,590.58100,032,695.4174,661,638.98
二、投资活动产生的现金流量:
  收回投资收到的现金392,348,493.99186,166,395.15361,108,866.91311,473,424.09
  取得投资收益收到的现金5,858.95---
  处置固定资产、无形资产和其他长期资产收回的现金净额48,000-1,600-
  投资活动现金流入小计392,402,352.94186,166,395.15361,110,466.91311,473,424.09
  购建固定资产、无形资产和其他长期资产支付的现金1,580,102238,2006,980,695.54,029,405.5
  投资支付的现金338,100,000162,000,000450,559,800.4380,759,800.4
  投资活动现金流出小计339,680,102162,238,200457,540,495.9384,789,205.9
  投资活动产生的现金流量净额52,722,250.9423,928,195.15-96,430,028.99-73,315,781.81
三、筹资活动产生的现金流量:
  取得借款收到的现金495,984.32495,984.321,331,613.621,331,613.62
  收到其他与筹资活动有关的现金--14,182,80014,182,800
  筹资活动现金流入小计495,984.32495,984.3215,514,413.6215,514,413.62
  分配股利、利润或偿付利息支付的现金35,535,500-35,535,50035,535,500
  支付其他与筹资活动有关的现金315,390.36157,695.18630,924.8474,034.86
  筹资活动现金流出小计35,850,890.36157,695.1836,166,424.836,009,534.86
  筹资活动产生的现金流量净额-35,354,906.04338,289.14-20,652,011.18-20,495,121.24
四、汇率变动对现金及现金等价物的影响-779,574.04-324,759.84-153,330.4331,809.41
五、现金及现金等价物净增加额19,495,637.0724,231,315.03-17,202,675.19-19,117,454.66
  加:期初现金及现金等价物余额19,237,898.9919,237,898.9936,440,574.1836,440,574.18
  期末现金及现金等价物余额38,733,536.0643,469,214.0219,237,898.9917,323,119.52
补充资料:
  净利润6,414,601.68-41,257,977.62-
  资产减值准备3,220,552.27-1,428,271.68-
  固定资产和投资性房地产折旧14,139,937.15-29,847,539.16-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,139,937.15-29,847,539.16-
  无形资产摊销1,860,343.79-3,417,950.33-
  长期待摊费用摊销409,728.96-255,874.63-
  处置固定资产、无形资产和其他长期资产的损失-47,058.82---
  固定资产报废损失6,009.35-25,482.94-
  公允价值变动损失-63,829.96--196,719.6-
  财务费用870,151.37-269,039.23-
  投资损失-5,308,817.76--12,251,556.96-
  递延所得税355,030.24-487,459.63-
  其中:递延所得税资产减少--339,323.34-
    递延所得税负债增加355,030.24-148,136.29-
  存货的减少-5,181,996.85--6,239,013.96-
  经营性应收项目的减少409,507.73-32,521,505.62-
  经营性应付项目的增加-16,972,710.92-1,193,449.95-
  其他1,674,798.25-8,694,693.54-
  现金的期末余额38,733,536.06-19,237,898.99-
  减:现金的期初余额19,237,898.99-36,440,574.18-
  现金及现金等价物的净增加额19,495,637.07--17,202,675.19-
公告日期2026-08-242026-04-282026-04-282025-10-28
审计意见(境内)标准无保留意见
TOP↑